Telehealth stories
AI is helping hospitals cut scan times, clear backlogs and spot disease earlier, while doctors still keep final say over treatment.
Patients are gaining faster access to test results as default uploads lifted weekly sharing of pathology and imaging reports to more than 5 million.
A delayed US product launch and helium supply snags trimmed sales, even as the medical tech group still delivered record FY26 revenue of AUD $60.3 million.
Remote responders and field teams gain a faster way to restore communications where fixed networks are absent or damaged.
Wearable monitoring could give asthma patients up to 72 hours' warning of worsening symptoms after a three-year UK-Singapore trial.
Older adults are far more likely to doubt digital messages, as a survey finds 41% of UK and US consumers question if they are genuine.
Backing will fund trials, regulatory work and prototype development as Zuuka targets US demand for home-based insulin delivery.
Funding will help Flok Health expand its NHS-backed AI physiotherapy service beyond back pain, as waiting lists for MSK care keep rising.
Employers and health plans are seeking ways to curb soaring obesity-drug bills as Ilant adds USD $15 million and expands care.
Paperwork is driving rapid adoption, with most Australian clinicians using AI daily and many doing so without formal guidance.
Users will now be able to track moles, UV exposure and skin changes over time as the app shifts towards preventive care and referrals.
People in rural Australia can now reach specialist anxiety care sooner, with secure video consultations replacing long trips and clinic waits.
Patients seeking jobs or care may face bias from chatbots, with a new study finding health stigma can skew AI outputs in subtle ways.
Patients could miss vital appointment and medication texts if healthcare providers fail to register before messages are labelled “Unverified”.
Australian patients could reach specialists far faster as TP's Bali hub cuts referral waits from days to minutes for providers under pressure.
Healthcare and AI start-ups dominate the shortlist, as investors prepare to hear pitches from firms tackling accessibility, childcare and drug delivery.
The contactless sensor aims to spot overnight health changes in older adults before daytime symptoms become visible, aiding care teams.
Funding will back trials and regulatory work as the New Zealand start-up aims to bring a smaller, reusable insulin device to the US market.
The multi-year project is meant to cut costs and give IHH Healthcare real-time data as it replaces fragmented systems across three Asian markets.
NHS patients could be routed faster and more accurately after a UK-built model outperformed GPs and rival AI in triage tests.
